Free · 13,591 studies indexed

lighttherapyresearch.com is a free index of research on photobiomodulation and light therapy, gathered from the world’s journals and trial registries.

Sections
Devices & Dosimetry

Efficacy and Safety of Topical Silymarin Versus Low Fluence 1064-nm Q Switched Nd:YAG Laser in the Treatment of Melasma: A Comparative Randomized Trial

Both low fluence Q switched ND:YAG 1064-nm laser and topical silymarin cream appear to be safe and effective modalities in the treatment of melasma. © 2021 Wiley Periodicals LLC.

Excerpt from the paper’s abstract. Read the full paper for the details.

AI-generated summary

The authors randomized 50 women with melasma to six sessions of low fluence 1064-nm Q-switched Nd:YAG laser or topical silymarin cream for three months. Both groups showed significant reductions in melasma severity with no recorded side effects, and the groups did not differ significantly. The study is small and short-term.

Participants
50
Who or what was studied
Women with melasma
Wavelengths
1064 nm
Limits stated in the abstract
Small, short-term randomized trial of 50 patients evaluated only over the short term.

Written by an AI model from this paper’s abstract only and checked automatically against it, but it can still be wrong. It is not medical advice. Read the full paper. See the editorial policy.

Abstract

The full abstract is not shown here because it is protected by the publisher’s copyright. Read it on onlinelibrary.wiley.com.

Record from PubMed, a service of the National Library of Medicine.

How to read a trial: what to check before relying on this kind of research.

Terms in this paper: Fluence, Laser. Each links to its definition in the glossary.

A summary of published research, not medical advice. One study rarely settles a question. See the disclaimer and how to read research.

Related studies

Devices & Dosimetry

Lasers for Melasma

Maintenance treatment is crucial to prevent recurrence. Despite advancements, laser treatments must be approached cautiously due to risks like postinflammatory hyperpigmentation, especially in darker skin types.

Review · May 13, 2026 · Campos V et al.